HyperMabs is a biopharmaceutical company that designs and develops innovative monoclonal antibody-based therapeutics for life threatening diseases including COVID-19. We believe in connecting rigorous science with our innate sense of urgency to rapidly generate breakthrough therapies for patients in... Read more